Bipartisan ‘pill penalty’ fix and other bills vie for inclusion in reconciliation packagenews2025-02-28T19:34:05+00:00February 28th, 2025|Endpoints News|
Merck says Keytruda could be up next for IRA price cutsnews2025-02-26T12:09:48+00:00February 26th, 2025|Endpoints News|
Court orders CVS to comply with the FTC’s PBM-related investigationnews2025-02-26T11:37:37+00:00February 26th, 2025|Endpoints News|
Compounders sue FDA over end of semaglutide shortagenews2025-02-25T20:46:35+00:00February 25th, 2025|Endpoints News|
Boehringer Ingelheim wins jury verdict in Zantac retrial in Illinoisnews2025-02-25T18:59:54+00:00February 25th, 2025|Endpoints News|
J&J seeks to stop Samsung Bioepis from licensing Stelara biosimilarnews2025-02-25T17:47:35+00:00February 25th, 2025|Endpoints News|
Deerfield sues Alcon over alleged scheme to obstruct Aurion’s IPOnews2025-02-24T21:02:34+00:00February 24th, 2025|Endpoints News|
Trump’s HHS defends drug price negotiations in Novartis suitnews2025-02-20T20:33:22+00:00February 20th, 2025|Endpoints News|
Drugmakers tell court to keep hospitals out of their 340B rebate suitsnews2025-02-20T20:21:31+00:00February 20th, 2025|Endpoints News|
Updated: Federal government defends lab-developed test rule in Texas courtnews2025-02-19T20:40:35+00:00February 19th, 2025|Endpoints News|
